(±)13(14)-DiHDPA (Synonyms: 13(14)-DiHDPA, 13(14)-DiHDoPE, 13,14-DiHDPE) |
| カタログ番号GC41648 |
(±)13(14)-DiHDPAは、サイトクロムP450エポキシゲナーゼによる酸化によって生成されるドコサヘキサエン酸の代謝物です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1345275-24-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis.
Review for (±)13(14)-DiHDPA
Average Rating: 5 (Based on Reviews and 23 reference(s) in Google Scholar.)
Review for (±)13(14)-DiHDPA
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *